Shifting Medicine Forward

Drawing on a deep understanding of the underlying causes, Ichnos Sciences is pursuing truly disease-centric therapies in oncology. We strive to develop novel assets and find new answers to some of medicine’s greatest challenges. Because the world is waiting.

Our path toward disease-centric therapies

Oncology Pipeline
Candidate Target Preclinical Phase 1 Phase 2 Phase 3 Status
ISB 1342 CD38 x CD3 BEAT® 1.0
bispecific antibody
Relapsed/Refractory Multiple Myeloma
      Phase 1 Enrolling
ISB 1442 CD38 x CD47 BEAT® 2.0 bispecific antibody
Relapsed/Refractory Multiple Myeloma
      IND-Enabling Studies
ISB 2001 TREAT™ trispecific antibody
Hematologic Malignancies
      Discovery
ISB 2004 BEAT® 2.0 bispecific antibody
Hematologic Malignancies/ Solid Tumors
      Discovery
ISB 2005 TREAT™ trispecific antibody
Hematologic Malignancies
      Discovery
oncology pipeline
Compound:
ISB 1342
Target:
CD38 x CD3 BEAT® 1.0
bispecific antibody
Indication:
Relapsed/Refractory Multiple Myeloma
Phase:
phase-1
Status:
Phase 1 Enrolling
Compound:
ISB 1442
Target:
CD38 x CD47 BEAT® 2.0 bispecific antibody
Indication:
Relapsed/Refractory Multiple Myeloma
Phase:
preclinical
Status:
IND-Enabling Studies
Compound:
ISB 2001
Target:
TREAT™ trispecific antibody
Indication:
Hematologic Malignancies
Phase:
preclinical
Status:
Discovery
Compound:
ISB 2004
Target:
BEAT® 2.0 bispecific antibody
Indication:
Hematologic Malignancies/ Solid Tumors
Phase:
preclinical
Status:
Discovery
Compound:
ISB 2005
Target:
TREAT™ trispecific antibody
Indication:
Hematologic Malignancies
Phase:
preclinical
Status:
Discovery

BEAT®: Bispecific Engagement by Antibodies based on the T-cell receptor
TREAT™: Trispecific Engagement by Antibodies based on the T-cell receptor

Note: Assets that were previously identified as GBR XXXX are now identified as ISB XXXX.

Interested in partnering with Ichnos Sciences? Contact us at Corporate.Communications@ichnossciences.com.

Out-licensing opportunities available for biologics in autoimmune diseases.

Learn more

View Career Opportunities

All Locations

The links above are provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.

X
Concerning Your Privacy
Access to an Ichnos Site may be monitored by Ichnos. If monitored, the requesting URLs, the machine originating the request and the time of the request are logged for access statistics and security purposes. Your use and access of an Ichnos Site constitutes your consent to such general monitoring. Please see the Ichnos Privacy Policy and Cookie Notice for details on how information from the Site may be gathered and used.